C. Nicholson
Director/Board Member at ADVERUM BIOTECHNOLOGIES, INC.
Net worth: 2 607 $ as of 2024-03-30
Profile
C.
David Nicholson is currently the Vice Chairman at Transcelerate Biopharma, Inc., the Chairman at Exscientia AI Ltd., the Non-Executive Chairman at Wild Bioscience Ltd., the Director at Science Exchange, Inc., the Lead Independent Director at Actinium Pharmaceuticals, Inc., the Independent Director at Adverum Biotechnologies, Inc., the Director at Tarus Therapeutics, Inc., and the Director at Volastra Therapeutics, Inc. He is also an Operational Partner at Gilde Healthcare.
In his former positions, Dr. Nicholson served as the Non-Executive Chairman at Exscientia Plc, a Director at Actinium Pharmaceuticals, Inc., a Director at Cactus Ventures, Inc., a Senior Vice President at Forest Laboratories, Inc., the Vice President-Licensing & Knowledge Management at Merck & Co., Inc., the SVP-Global Project Management & Drug Safety at Schering-Plough Corp., the Chief Technology Officer & Executive VP at Bayer CropScience AG, and the Executive Vice President-Research & Development at Organon International, Inc. and Organon Biosciences, Inc. He was also the Executive VP, Chief Research & Development Officer at Allergan Ltd.
(Ireland) and the CTO, Head-Research & Development at Bayer Crop Science Solutions LLC.
Dr. Nicholson obtained his undergraduate degree from The University of Manchester in 1975 and his doctorate degree from The University of Wales in 1980.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
2023-12-27 | 333 ( 0.00% ) | 2 607 $ | 2024-03-30 |
C. Nicholson active positions
Companies | Position | Start |
---|---|---|
ACTINIUM PHARMACEUTICALS, INC. | Director/Board Member | 2007-12-31 |
ADVERUM BIOTECHNOLOGIES, INC. | Director/Board Member | 2023-11-02 |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Director/Board Member | - |
WILD BIOSCIENCE LTD
WILD BIOSCIENCE LTD Miscellaneous Commercial ServicesCommercial Services Wild Bioscience Ltd. is a British crop improvement company that specializes in providing carbon mitigation, yield enhancement, and farm productivity solutions. The company is based in Abingdon, UK. It was founded in 2021 by Ross Hendron and Steven Bryan Kelly, with Ross Hendron serving as the CEO since 2021. | Chairman | 2023-11-02 |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Chairman | 2020-09-30 |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a private company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Director/Board Member | 2020-05-13 |
Science Exchange, Inc.
Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Director/Board Member | 2018-06-27 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | 2017-09-13 |
Gilde Healthcare | Corporate Officer/Principal | - |
Former positions of C. Nicholson
Companies | Position | End |
---|---|---|
░░░░░░░░░░ ░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░ ░░░░░░░ ░░░░░░░░░ ░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░ ░░░░░░░░░░░ ░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of C. Nicholson
The University of Manchester | Undergraduate Degree |
The University of Wales | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 4 |
---|---|
MERCK & CO., INC. | Health Technology |
ACTINIUM PHARMACEUTICALS, INC. | Health Technology |
ADVERUM BIOTECHNOLOGIES, INC. | Health Technology |
EXSCIENTIA PLC | Health Technology |
Private companies | 16 |
---|---|
Forest Laboratories, Inc.
Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Schering-Plough Corp.
Schering-Plough Corp. Pharmaceuticals: MajorHealth Technology Schering Plough Corp. manufactures and sells pharmaceuticals, consumer and animal health care products. The firm discovers, develops, manufactures and markets advanced drug therapies. The company is headquartered in Kenilworth, NJ. | Health Technology |
Actinium Pharmaceuticals, Inc. /Old/
Actinium Pharmaceuticals, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Actinium Pharmaceuticals, Inc. provides development and commercialization of alpha particle immunotherapeutics services. It conducts research based on a patient position for the utilization of actinium-225 and bismuth-213. The company has offices in Oak Ridge, TN and Alexandria, VA. Actinium Pharmaceuticals was founded in 1993 and is headquartered in Florham Park, NJ. | Commercial Services |
Cactus Ventures, Inc.
Cactus Ventures, Inc. Financial ConglomeratesFinance Cactus Ventures, Inc. operates as a blank check company. Cactus Ventures intends to locate and negotiate with a business entity for the merger of that target company into the company. The company was founded on October 6, 1997 and is headquartered in Carson City, NV. | Finance |
Bayer CropScience AG
Bayer CropScience AG Chemicals: AgriculturalProcess Industries Bayer CropScience AG manufactures and distributes pesticides, and vegetable seeds. Its products include crops such as cotton, fruits and vegetables, oil seeds and wheat, brands includes fungicides, herbicides and seeds growth. The company was founded in 1979 and is headquartered In Monheim am Rhein, Germany. | Process Industries |
Organon International, Inc.
Organon International, Inc. Pharmaceuticals: MajorHealth Technology Organon International, Inc. manufactures and markets pharmaceutical products. It develops therapeutics in the fields such as gynecology, fertility, osteoporosis, and anesthesia. The company was founded in 1923 and is located in Roseland, NJ. | Health Technology |
Organon Biosciences, Inc. | |
Allergan Ltd. (Ireland)
Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Science Exchange, Inc.
Science Exchange, Inc. Internet Software/ServicesTechnology Services Science Exchange, Inc. operates an online marketplace for outsourcing science experiments. The firm is a community marketplace for scientists to list, discover access, and pay for scientific services from institutions around the world. The company was founded by Elizabeth Iorns, Ryan Abbott and Daniel John Knox in 2011 and is headquartered in San Francisco, CA. | Technology Services |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
Exscientia AI Ltd.
Exscientia AI Ltd. Pharmaceuticals: GenericHealth Technology Exscientia AI Ltd. is an artificial intelligence (AI) driven pharmatech company, which develops bi-specific small molecule immuno-oncology therapeutics. The firm offers phenotypic drug design and selective single target molecules. The company was founded by Andrew Lee Hopkins in July 2012 and is headquartered in Oxford, the United Kingdom. | Health Technology |
Tarus Therapeutics, Inc.
Tarus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Part of Portage Biotech, Inc., Tarus Therapeutics, Inc. is a private company developing small molecule inhibitors of adenosine receptors for cancer immunotherapy and select non-oncology indications. The company is based in New York, NY. The company has a comprehensive portfolio of adenosine receptor antagonists in development, including both first-in-class and programs. The company was founded by Sushant Kumar and Peter R. Molloy, with Sushant Kumar serving as CEO since incorporation. Tarus Therapeutics was acquired by Portage Biotech, Inc. on July 05, 2022 for $49.20 million. | Health Technology |
Volastra Therapeutics, Inc.
Volastra Therapeutics, Inc. BiotechnologyHealth Technology Volastra Therapeutics, Inc. develops novel therapies for patients with metastatic cancers. The company was founded by Lewis Cantley, Samuel Bakhoum and Olivier Elemento and is headquartered in Boston, MA. | Health Technology |
Bayer Crop Science Solutions LLC | |
Gilde Healthcare | |
WILD BIOSCIENCE LTD
WILD BIOSCIENCE LTD Miscellaneous Commercial ServicesCommercial Services Wild Bioscience Ltd. is a British crop improvement company that specializes in providing carbon mitigation, yield enhancement, and farm productivity solutions. The company is based in Abingdon, UK. It was founded in 2021 by Ross Hendron and Steven Bryan Kelly, with Ross Hendron serving as the CEO since 2021. | Commercial Services |
- Stock Market
- Insiders
- C. Nicholson